Circulating hematopoietic stem cells serve as novel targets for in utero gene therapy.

B. Murdoch, L. Gallacher, C. Awaraji, D. A. Hess, M. Keeney, K. Jay, K. Chadwick, S. R. Fowley, K. Howson-Jan, I. Chin Yee, D. Wu, E. D. Srour, F. Fellows, M. Bhatia

Research output: Contribution to journalArticle

20 Scopus citations
Original languageEnglish (US)
Pages (from-to)1628-1630
Number of pages3
JournalThe FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Volume15
Issue number9
StatePublished - Jul 2001

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Murdoch, B., Gallacher, L., Awaraji, C., Hess, D. A., Keeney, M., Jay, K., Chadwick, K., Fowley, S. R., Howson-Jan, K., Chin Yee, I., Wu, D., Srour, E. D., Fellows, F., & Bhatia, M. (2001). Circulating hematopoietic stem cells serve as novel targets for in utero gene therapy. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 15(9), 1628-1630.